These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31803968)

  • 1. Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice.
    Litten RZ; Falk DE; Ryan ML; Fertig J; Leggio L
    Alcohol Clin Exp Res; 2020 Jan; 44(1):23-35. PubMed ID: 31803968
    [No Abstract]   [Full Text] [Related]  

  • 2. Overcoming the "Valley of Death" in Medications Development for Alcohol Use Disorder.
    Ray LA; Bujarski S; Roche DJO; Magill M
    Alcohol Clin Exp Res; 2018 Sep; 42(9):1612-1622. PubMed ID: 29969156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary on Falk.
    Meyer RE
    Alcohol Clin Exp Res; 2011 Feb; 35(2):191-3. PubMed ID: 21261665
    [No Abstract]   [Full Text] [Related]  

  • 4. Perspectives on the neuroscience of alcohol from the National Institute on Alcohol Abuse and Alcoholism.
    Reilly MT; Noronha A; Warren K
    Handb Clin Neurol; 2014; 125():15-29. PubMed ID: 25307566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapies and personalized medicine for alcohol use disorder: a review.
    Lohoff FW
    Pharmacogenomics; 2020 Oct; 21(15):1117-1138. PubMed ID: 32807012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized Medicine of Alcohol Addiction: Pharmacogenomics and Beyond.
    Ragia G; Manolopoulos VG
    Curr Pharm Biotechnol; 2017; 18(3):221-230. PubMed ID: 28240173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research opportunities for medications to treat alcohol dependence: addressing stakeholders' needs.
    Litten RZ; Falk D; Ryan M; Fertig J
    Alcohol Clin Exp Res; 2014 Jan; 38(1):27-32. PubMed ID: 23889161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies.
    Leggio L; Falk DE; Ryan ML; Fertig J; Litten RZ
    Handb Exp Pharmacol; 2020; 258():443-462. PubMed ID: 31628604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Looking Back, Looking Forward: Current Medications and Innovative Potential Medications to Treat Alcohol Use Disorder.
    Mason BJ
    Alcohol Res; 2022; 42(1):11. PubMed ID: 36320345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focus on: Neuroscience and treatment: the potential of neuroscience to inform treatment.
    Koob GF
    Alcohol Res Health; 2010; 33(1-2):144-51. PubMed ID: 23579944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discussion: The FDA is Unprepared for Personalized Medicine.
    Tabarrok A
    Biostatistics; 2017 Jul; 18(3):403-404. PubMed ID: 28633317
    [No Abstract]   [Full Text] [Related]  

  • 12. NIAAA: advancing alcohol research for 40 years.
    Warren KR; Hewitt BG
    Alcohol Res Health; 2010; 33(1-2):5-17. PubMed ID: 23579932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More Treatments on Deck for Alcohol Use Disorder.
    Lyon J
    JAMA; 2017 Jun; 317(22):2267-2269. PubMed ID: 28538998
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioresponsive nanostructured systems for sustained naltrexone release and treatment of alcohol use disorder: Development and biological evaluation.
    Santos RA; Rae M; Dartora VFMC; Matos JKR; Camarini R; Lopes LB
    Int J Pharm; 2020 Jul; 585():119474. PubMed ID: 32473371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel medication targets for the treatment of alcoholism: preclinical studies.
    Rezvani AH; Lawrence AJ; Arolfo MP; Levin ED; Overstreet DH
    Recent Pat CNS Drug Discov; 2012 Aug; 7(2):151-62. PubMed ID: 22574676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy for alcohol dependence: A stratified approach.
    Thompson A; Owens L; Pushpakom SP; Faizal M; Pirmohamed M
    Pharmacol Ther; 2015 Sep; 153():10-24. PubMed ID: 25985735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological basis of the screening of drugs for differentiated pharmacotherapy of alcoholism].
    Val'dman AV; Maĭskiĭ AI; Kampov-Polevoĭ AB; Treskov VG; Drozdov ES
    Vestn Akad Med Nauk SSSR; 1988; (3):28-32. PubMed ID: 3388968
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacotherapy for Alcohol Use Disorder.
    Holt SR; Tobin DG
    Med Clin North Am; 2018 Jul; 102(4):653-666. PubMed ID: 29933821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Pharmacotherapy Development: Human Clinical Studies.
    Litten RZ; Falk DE; Ryan ML; Fertig J; Leggio L
    Handb Exp Pharmacol; 2018; 248():579-613. PubMed ID: 29294197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Molecule to Patient and Ways to Get the Dose Precisely Right.
    Vinks AA
    Clin Pharmacol Ther; 2019 Mar; 105(3):534-537. PubMed ID: 30773626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.